Cutaneous melanoma (CM) is potentially the most dangerous form of skin tumor and causes
90% of skin cancer mortality. A unique collaboration of multi-disciplinary experts from the …

Cutaneous melanoma is a malignancy arising from melanocytes of the skin. Incidence rates
are rising, particularly in White populations. Cutaneous melanoma is typically driven by …

Over the past few years, the NCCN Guidelines for Melanoma: Cutaneous have been
expanded to include pathways for treatment of microscopic satellitosis (added in v2. 2020) …

PURPOSE The first randomized trial of adjuvant treatment with checkpoint inhibitor in stage
II melanoma reported a significant reduction in risk of tumor recurrence. This study evaluates …

The primary cause of the increase in melanoma incidence in the United States has been
suggested to be overdiagnosis. We used Surveillance, Epidemiology, and End Result …

Cancer is caused by the accumulation of pathogenic alterations of the genome and
epigenome that result in permanent changes that disrupt cellular homeostasis. The genes …

Despite significant progress in the development of treatment options, melanoma remains a
leading cause of death due to skin cancer. Advances in our understanding of the genetic …

Artificial intelligence is poised to rapidly reshape many fields, including that of skin cancer
screening and diagnosis, both as a disruptive and assistive technology. Together with the …

Background Prognostic assessment of cutaneous melanoma relies on historical,
clinicopathological, and phenotypic risk factors according to American Joint Committee on …

Background It has been claimed, without supporting evidence, that knowledge of sentinel
node (SN) status does not provide more accurate prognostic information than basic …